Phase I Irinotecan, 5-Fluorouracil and Leucovorin Combination

NCT00507091 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic
Colorectal
Adenocarcinoma

Interventions

DRUG: ZD6474 (vandetanib) 100mg
DRUG: Irinotecan
DRUG: 5-Fluorouracil
DRUG: Leucovorin
DRUG: ZD6474 (vandetanib) 300mg

Sponsor

Genzyme, a Sanofi Company